Roundtable Session – Successes in Modalities Beyond Small Molecules

Time: 3:00 pm
day: Day One Track D


As this community continues progress targeting RAS mutants harnessing novel modalities, this session will lead the discussion into existing literature, data and ongoing challenges with RAS-mutant drugs leveraging novel degradation strategies, immune therapies and molecular glue approaches